Predicted Risk of End Stage Liver Disease with Continued Standard of Care and Subsequent Addition of Obeticholic Acid in Patients with PBC

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Carbone M, Jones D, Mells GF, Pencek R, Marmon T, Shapiro D

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016

Year of Conference: 2016

Pages: 184A-185A

Print publication date: 01/10/2016

Acceptance date: 02/04/2016

ISSN: 0270-9139

Publisher: Wiley-Blackwell

URL: http://doi.org/10.1002/hep.28797

DOI: 10.1002/hep.28797

Series Title: Hepatology

ePrints